Dr. Silver explained that HIFU destroys only the diseased part of the prostate, which means that side effects like urinary incontinence and not being able to have sex are less likely. This is unlike radical surgery or radiation which both are riskier for these 2 side effects. Also HIFU is done quickly (approximately two to three hours), in a single session and at an outpatient surgery center, away from the main hospital, so I could get in and out quickly, and avoid any risk of contracting Covid.
Christopher Weight, MD, Center Director of Urologic Oncology at Cleveland Clinic joins the Cancer Advances podcast to discuss how high-intensity focused ultrasound (HIFU), a type of focal therapy for treating localized prostate cancer, is emerging as an alternative to more traditional treatments, such as surgery and radiation for select patients.
Shane shares the experience he had navigating the Covid pandemic as he searched for the prostate cancer treatment that he felt best suited his needs. With financial support raised from a GO-Fund-Me project as well as help and guidance from a number of resources, including medical professionals, family and friends, Shane decided to become the first man in Louisiana to treat his prostate cancer with high intensity focused ultrasound – or HIFU.
Although partial-gland therapies, also known as focal therapies, have been incorporated into the surgical treatment pathway of nearly every solid organ system, the prostate has been particularly challenging due mainly to 2 concerns: cancer multifocality and the difficulties of accurately imaging the boundaries of a distinct tumor(s) as typically occurs in other organs, such as the kidney. Despite these challenges, however, the slow but steady acceptance of the concept of focal therapy for prostate cancer has been growing over the past 2 decades, with gratitude to the dedicated individuals who have had the foresight to propel focal therapy to eventually become a standard treatment for select men. Support for the development of image-targeted interventions is also extended to our industry partners and collaborative scientists who continue to push the envelope on technical enhancements and new discoveries that aid in the detection, characterization, and image-guided treatment of such neoplasms.
Focal therapy HIFU is appropriate for patients whose prostate cancer is diagnosed at a higher grade and stage, but is still confined to the prostate. We use guided imagery to locate and destroy only the diseased portion of the prostate. It is done quickly (approximately two to three hours), in a single session at the Maimonides’ ambulatory surgery center. Patients like the ability to get in and out, with minimal exposure to the healthcare system. Focal therapy HIFU is ideal for this.
Every three minutes, a man is diagnosed with prostate cancer. It is estimated that one out of nine men will be diagnosed with prostate cancer in their lifetime. That’s why it’s important to help spread awareness and learn about prostate health and protection.
Prostate cancer is the second-most common cancer in American men but an innovative treatment (HIFU) is helping many to maintain quality of life.
Thanks to advances in prostate cancer treatments–and the fact that all four men were diagnosed with localized prostate cancer–they were able to take advantage of a new class of precision robotic technologies to treat only the diseased portion of their prostate.
Termed focal therapy, this precision robotic system is used for a noninvasive, bloodless procedure designed to destroy precisely targeted prostate cancer cells, using high intensity focused ultrasound waves (HIFU), while leaving the remaining healthy prostate intact. This is an exciting new alternative to more radical treatments requiring surgery or radiation to treat the entire prostate rather than focusing only on the diseased area.